Hongwei Wu
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Suspected acquired factor XIII deficiency in a man living with HIV: diagnostic and therapeutic challenges in recurrent spontaneous hemorrhage: a case report.
Journal: Frontiers in medicine
Published: December 17, 2025
Effect of the IDH1 inhibitor combined with hypomethylating agents on acute myeloid leukemia.
Journal: Tumori
Published: June 20, 2025
Venetoclax plus decitabine, cytarabine, aclarubicin, and G-CSF in adults with newly diagnosed acute myeloid leukemia: A multicenter, retrospective study.
Journal: International journal of cancer
Published: June 19, 2025
Systematic exploration of prognostic alternative splicing events related to tumor immune microenvironment of Clear Cell Renal Cell Carcinoma.
Journal: Cancer biomarkers : section A of Disease markers
Published: April 02, 2025
Molecular Mechanisms and Therapeutic Prospects of Immunotherapy and Targeted Therapy in Primary Central Nervous System Lymphoma.
Journal: Technology in cancer research & treatment
Published: February 06, 2025
The systemic inflammation response index (SIRI) predicts survival in advanced non-small cell lung cancer patients undergoing immunotherapy and the construction of a nomogram model.
Journal: Frontiers in immunology
Published: October 24, 2024
Efficacy and toxicity of lurbinectedin in subsequent systemic therapy of extensive-stage small cell lung cancer: a meta-analysis.
Journal: BMC cancer
Published: July 11, 2024
Effect of the STK11 mutation on therapeutic efficacy and prognosis in patients with non-small cell lung cancer: a comprehensive study based on meta-analyses and bioinformatics analyses.
Journal: BMC cancer
Published: November 23, 2023
Neural stem cell-derived exosomes and regeneration: cell-free therapeutic strategies for traumatic brain injury.
Journal: Stem cell research & therapy
Published: January 18, 2023
MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1.
Journal: Experimental cell research
Published: October 14, 2015
Plumbagin inhibits cell proliferation and promotes apoptosis in multiple myeloma cells through inhibition of the PI3K/Akt-mTOR pathway.
Journal: Oncology letters
Published: March 27, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026